Psilocybin Therapy Protocol With Psychological Support for Anxiety Care

Solution Overview

Problem

There is a need for improved compositions and methods for treating anxiety disorders, headache disorders, and eating disorders using psilocybin.

Innovation Solution

Administering a therapeutically effective amount of psilocybin or its active metabolite to subjects in need of treatment, optionally with highly pure crystalline psilocybin in the form of Polymorph A, along with psychological support sessions before and after administration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing treatments are used for anxiety disorders, headache disorders, and eating disorders, then current standard therapies are applied, but treatment effectiveness is inadequate

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical parameter by introducing psilocybin, a psychedelic compound, as an alternative active ingredient to existing treatments. This parameter change enables effective treatment for anxiety disorders, headache disorders, and eating disorders where current therapies have proven inadequate, thereby improving treatment effectiveness while expanding therapeutic versatility

Inventive Principle:
Principle #35Parameter changes

2Reliability

If psilocybin is administered to treat disorders, then clinical benefits in neural plasticity and cognitive function are achieved, but treatment protocols require psychological support sessions increasing complexity

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The treatment protocol is segmented into distinct components: (1) administration of psilocybin at specific dosages, (2) pre-session psychological preparation, and (3) post-session integration therapy. This segmentation allows each component to be optimized independently while maintaining overall treatment effectiveness for neural plasticity and cognitive function improvements

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Psychological support sessions are conducted preliminarily before psilocybin administration to prepare patients mentally and emotionally. This preliminary action ensures patients are properly oriented and supported, which enhances the clinical benefits of neural plasticity and cognitive function while making the complexity manageable through structured preparation

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS12611418B2Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
Publication Date: 2026.04.28
  • US12611418B2 patent drawing
  • US12611418B2 patent drawing
  • US12611418B2 patent drawing

AI summary

The disclosure provides methods for treating a subject in need thereof comprising administering to the subject a therapeutically-effective dose of psilocybin. The methods described herein may be used to treat a variety of diseases, disorders, and conditions. For example, the methods may be used to treat anxiety disorders, eating disorders, and headache disorders.